BCM
BML Capital Management Portfolio holdings
AUM
$131M
This Quarter Return
+21.02%
1 Year Return
+89.45%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$161M
AUM Growth
+$161M
(-5.3%)
Cap. Flow
-$10.8M
Cap. Flow
% of AUM
-6.74%
Top 10 Holdings %
Top 10 Hldgs %
86.68%
Holding
32
New
3
Increased
7
Reduced
5
Closed
7
Top Buys
| 1 |
ESSA Pharma
EPIX
|
$7.56M |
| 2 |
IMA
ImageneBio, Inc. Common Stock
IMA
|
$4.69M |
| 3 |
Atea Pharmaceuticals
AVIR
|
$3.21M |
| 4 |
PMV Pharmaceuticals
PMVP
|
$2.68M |
| 5 |
Athira Pharma
ATHA
|
$1.63M |
Top Sells
Sector Composition
| 1 | Healthcare | 82.88% |
| 2 | Technology | 0.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Aclaris Therapeutics
ACRS
$209M
| $35.3M | 21.95% | 14,250,000 | – | – |
|
2
iShares 0-3 Month Treasury Bond ETF
SGOV
$56.1B
| $26.1M | 16.2% | 260,000 -10,000 | -4% | -$1M |
|
|
3
Atea Pharmaceuticals
AVIR
$267M
| $25.5M | 15.83% | 7,608,312 +958,312 | +14% | +$3.21M |
|
4
Adverum Biotechnologies
ADVM
$64.6M
| $10.6M | 6.58% | 2,268,064 | – | – |
|
5
AN2 Therapeutics
ANTX
$30.1M
| $7.93M | 4.93% | 5,749,432 | – | – |
|
6
Instil Bio
TIL
$182M
| $7.64M | 4.74% | 400,000 +65,000 | +19% | +$1.24M |
|
|
7
ESSA Pharma
EPIX
$11.4M
| $7.56M | 4.69% | +4,221,546 | New | +$7.56M |
|
|
WHWK
8
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
| $6.63M | 4.12% | 2,100,000 +100,000 | +5% | +$316K |
|
9
Oramed Pharmaceuticals
ORMP
$90.2M
| $6.4M | 3.97% | 2,643,907 +457,716 | +21% | +$1.11M |
|
|
IMA
10
ImageneBio, Inc. Common Stock
IMA
$150M
| $5.88M | 3.65% | 3,585,866 +2,862,578 | +396% | +$4.69M |
|
|
11
PMV Pharmaceuticals
PMVP
$74.2M
| $5.23M | 3.25% | 3,466,684 +1,777,912 | +105% | +$2.68M |
|
|
ACHL
12
DELISTED
Achilles Therapeutics plc American Depositary Shares
ACHL
| $4.67M | 2.9% | 4,100,002 | – | – |
|
|
CNTB
13
Connect Biopharma
CNTB
$115M
| $2.89M | 1.79% | 2,093,232 | – | – |
|
14
Milestone Pharmaceuticals
MIST
$156M
| $2.68M | 1.67% | 1,136,091 | – | – |
|
|
15
Athira Pharma
ATHA
$15.3M
| $1.63M | 1.01% | +2,775,885 | New | +$1.63M |
|
16
Astrotech Corp
ASTC
$8.72M
| $1.48M | 0.92% | 220,410 | – | – |
|
17
Lisata Therapeutics
LSTA
$19.9M
| $848K | 0.53% | 284,669 | – | – |
|
|
PVLA
18
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| $506K | 0.31% | 42,130 | – | – |
|
19
VistaGen Therapeutics
VTGN
$102M
| $443K | 0.27% | 150,000 | – | – |
|
20
Kezar Life Sciences
KZR
$28.9M
| $327K | 0.2% | +48,668 | New | +$327K |
|
|
LENZ
21
LENZ Therapeutics
LENZ
$1.1B
| $268K | 0.17% | 9,271 -50,729 | -85% | -$1.46M |
|
22
NextCure
NXTC
$13.5M
| $211K | 0.13% | 273,536 -2,929 | -1% | -$2.26K |
|
23
Verrica Pharmaceuticals
VRCA
$52.8M
| $122K | 0.08% | 174,651 -5,349 | -3% | -$3.74K |
|
|
KLRS
24
Kalaris Therapeutics, Inc. Common Stock
KLRS
$76.3M
| $77.4K | 0.05% | 184,246 -418,840 | -69% | -$176K |
|
25
HilleVax
HLVX
$105M
| $43K | 0.03% | 20,760 +1,000 | +5% | +$2.07K |
|